<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">detstom</journal-id><journal-title-group><journal-title xml:lang="ru">Стоматология детского возраста и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric dentistry and dental prophylaxis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-3031</issn><issn pub-type="epub">1726-7218</issn><publisher><publisher-name>RPA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33925/1683-3031-2023-625</article-id><article-id custom-type="elpub" pub-id-type="custom">detstom-685</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Факторы риска развития злокачественных новообразований слизистой оболочки рта (обзор литературы). Часть 1. Эндогенные и биологические факторы</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors for malignant oral mucosal lesion development (literature review). Part 1. Endogenous and biological factors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2442-3361</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Луницына</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lunitsyna</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Луницына Юлия Васильевна, кандидат медицинских наук, доцент кафедры терапевтической стоматологии</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Yulia V. Lunitsyna, DMD, PhD, Associate Professor, Department of Operative Dentistry</p><p>Barnaul</p></bio><email xlink:type="simple">lunizyna.julja@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1080-5294</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазарев</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazarev</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лазарев Александр Федорович, доктор медицинских наук, профессор кафедры онкологии и лучевой терапии с курсом дополнительного профессионального образования</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Alexander F. Lazarev, MD, PhD, DSc, Professor, Department of Oncology and Radiation Therapy with the Course of Continuing Professional Education</p><p>Barnaul</p></bio><email xlink:type="simple">lasarev@akzs.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0437-0079</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Токмакова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tokmakova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Токмакова Светлана Ивановна, доктор медицинских наук, профессор, заведующая кафедрой терапевтической стоматологии</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Svetlana I. Tokmakova, DMD, PhD, DSc, Professor, Head of the Department of Operative Dentistry</p><p>Barnaul</p></bio><email xlink:type="simple">agmuterst@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7280-7709</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бондаренко Ольга Владимировна, кандидат медицинских наук, доцент кафедры терапевтической стоматологии</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Olga V. Bondarenko, DMD, PhD, Associate Professor, Department of Operative Dentistry</p><p>Barnaul</p></bio><email xlink:type="simple">bonda76@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Алтайский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2023</year></pub-date><volume>23</volume><issue>3</issue><fpage>271</fpage><lpage>280</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Луницына Ю.В., Лазарев А.Ф., Токмакова С.И., Бондаренко О.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Луницына Ю.В., Лазарев А.Ф., Токмакова С.И., Бондаренко О.В.</copyright-holder><copyright-holder xml:lang="en">Lunitsyna Y.V., Lazarev A.F., Tokmakova S.I., Bondarenko O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.detstom.ru/jour/article/view/685">https://www.detstom.ru/jour/article/view/685</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Рак слизистой оболочки рта (СОР) занимает шестнадцатое место по распространенности в мире. Высокий уровень смертности в значительной степени обусловлен бессимптомным течением заболевания на ранних стадиях заболевания, поздним выявлением, когда опухолевый процесс плохо поддается лечению. Для осуществления профилактики и диагностики злокачественных новообразований СОР на ранних стадиях необходимо определить влияние различных факторов риска и установить их взаимосвязь.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Определить степень влияния различных эндогенных и экзогенных факторов риска на развитие злокачественных новообразований слизистой оболочки рта по данным современной литературы, оценить их взаимосвязь.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Материалом исследования послужил анализ литературных данных из библиографических источников – Elsevier, PubMed, Elibrary, Google Академия, Medline, Cyberleninka. В исследование включали источники литературы на русском и английском языках. Первая часть обзора объединяет исследования, посвященные изучению влияния эндогенных и биологических факторов на риск развития злокачественных новообразований слизистой оболочки рта.</p></sec><sec><title>Результаты</title><p>Результаты. На основании современной литературы определены эндогенные и биологические факторы риска развития злокачественных новообразований слизистой оболочки рта. Отмечена высокая роль изменения микробиома, наличие дисбиоза у пациентов со злокачественными новообразованиями. Доказано непосредственное вовлечение грибков рода Candida в канцерогенез. Показана положительная корреляции между развитием рака СОР и наличием и тяжестью колонизации полости рта дрожжами, а также инфицированием вирусом папилломы человека. Определены хронические заболевания полости рта, которые подвержены злокачественной трансформации или способствуют развитию карцином, установлена их взаимосвязь с биологическими факторами риска, возрастом, полом пациента и продолжительностью течения.</p></sec><sec><title>Заключение</title><p>Заключение. Рассмотренные в данной части обзора исследования доказывают роль влияния эндогенных и биологических факторов на развитие злокачественных новообразований полости рта, определяют их взаимосвязь. Однако многие механизмы до настоящего времени остаются не изученными. Для осуществления эффективной первичной и вторичной профилактики необходимо совершенствовать и развивать мультидисциплинарный подход к методологии исследований, изучать комплексное воздействие всех групп факторов риска на развитие злокачественных новообразований слизистой оболочки рта.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. Oral mucosal cancer (OMC) is the sixteenth most common cancer worldwide. The high mortality rate is mainly due to the asymptomatic course of the disease in the early stages and late detection when the tumour process poorly responds to treatment. Determining the impact of various risk factors and establishing their relationship are necessary to prevent and diagnose malignant oral mucosal lesions in the early stages.</p></sec><sec><title>Purpose</title><p>Purpose. Based on the modern literature, the study aimed to determine the impact value of various internal and external risk factors on malignant oral mucosal lesion development and assess the risk factors’ relationship.</p></sec><sec><title>Material and methods</title><p>Material and methods. The research material included the analysis of literature from databases – Elsevier, PubMed, Elibrary, Google Academy, Medline and Cyberleninka. The study included literature sources in Russian and English.</p></sec><sec><title>Results</title><p>Results. Based on modern literature, we have determined endogenous and biological risk factors for malignant oral mucosal lesion development. The study noted the high role of microbiome changes and the presence of dysbiosis in patients with malignant neoplasms and proved the direct involvement of Candida fungi in carcinogenesis. The development of oral mucosal cancer and the presence and severity of oral yeast colonization and human papillomavirus infection showed a positive correlation. Chronic oral diseases, which are susceptible to malignant transformation or contribute to the development of carcinomas, have been identified, and their relationship has been established with biological risk factors, age, sex of the patient and duration of the disease course.</p></sec><sec><title>Conclusion</title><p>Conclusion. The studies considered in this part of the review prove the influence of endogenous and biological factors on the development of malignant neoplasms of the oral cavity and determine their relationship. However, many mechanisms remain unexplored to date. Effective primary and secondary prevention implementation needs improvement and the development of a multidisciplinary approach to research methodology, study the complex impact of all groups of risk factors on the development of malignant oral mucosal lesions.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>злокачественное новообразование полости рта</kwd><kwd>онкологическое заболевание полости рта</kwd><kwd>рак полости рта</kwd><kwd>карцинома полости рта</kwd><kwd>плоскоклеточный рак слизистой оболочки рта</kwd><kwd>предраковые заболевания полости рта</kwd><kwd>факторы риска</kwd><kwd>профилактика новообразований</kwd><kwd>персонализированная профилактика</kwd><kwd>предикторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>malignant oral mucosal lesion</kwd><kwd>mouth cancer</kwd><kwd>oral cancer</kwd><kwd>oral carcinoma</kwd><kwd>oral mucosal squamous cell carcinoma</kwd><kwd>precancerous oral diseases</kwd><kwd>risk factors</kwd><kwd>prevention of neoplasms</kwd><kwd>personalized prevention</kwd><kwd>predictors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Cancer Observatory. https://gco.iarc.fr/</mixed-citation><mixed-citation xml:lang="en">Global Cancer Observatory. https://gco.iarc.fr/</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451. doi: 10.1016/j.oraloncology.2021.105451</mixed-citation><mixed-citation xml:lang="en">Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451. doi: 10.1016/j.oraloncology.2021.105451</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofacial Surgery Clin North Am. 2014;26(2):123–41. doi: 10.1016/j.coms.2014.01.001</mixed-citation><mixed-citation xml:lang="en">Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofacial Surgery Clin North Am. 2014;26(2):123–41. doi: 10.1016/j.coms.2014.01.001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–94. doi: 10.5281/zenodo.192487</mixed-citation><mixed-citation xml:lang="en">Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–94. doi: 10.5281/zenodo.192487</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pires FR, Ramos AB, Oliveira JBC, Tavares AS, Luz PSR, Santos TCRB. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci: Revista FOB. 2013;21(5):460–7. doi: 10.1590/1679-775720130317</mixed-citation><mixed-citation xml:lang="en">Pires FR, Ramos AB, Oliveira JBC, Tavares AS, Luz PSR, Santos TCRB. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci: Revista FOB. 2013;21(5):460–7. doi: 10.1590/1679-775720130317</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479-490. doi: 10.6004/jnccn.2018.0026</mixed-citation><mixed-citation xml:lang="en">Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479-490. doi: 10.6004/jnccn.2018.0026</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chinn SB, Myers JN. Oral cavity carcinoma: Current management, controversies, and future directions. J Clin Oncol. 2015;33(29):3269–76. doi: 10.1200/JCO.2015.61.2929</mixed-citation><mixed-citation xml:lang="en">Chinn SB, Myers JN. Oral cavity carcinoma: Current management, controversies, and future directions. J Clin Oncol. 2015;33(29):3269–76. doi: 10.1200/JCO.2015.61.2929</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.v71.310.3322/caac.21660</mixed-citation><mixed-citation xml:lang="en">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.v71.310.3322/caac.21660</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492</mixed-citation><mixed-citation xml:lang="en">Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T, Wiesenfeld D. Oral Cancer. Aust Dent J. 2018;6:91-99. doi: 10.1111/adj.12594</mixed-citation><mixed-citation xml:lang="en">Wong T, Wiesenfeld D. Oral Cancer. Aust Dent J. 2018;6:91-99. doi: 10.1111/adj.12594.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chattopadhyay I, Verma M, Panda M. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer. Technol Cancer Res Treat. 2019;18:1533033819867354. doi: 10.1177/1533033819867354.</mixed-citation><mixed-citation xml:lang="en">Chattopadhyay I, Verma M, Panda M. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer. Technol Cancer Res Treat. 2019;18:1533033819867354. doi: 10.1177/1533033819867354.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">O'Grady I, Anderson A, O'Sullivan J. The interplay of the oral microbiome and alcohol consumption in oral squamous cell carcinomas. Oral Oncol. 2020;110:105011. doi: 10.1016/j.oraloncology.2020.105011</mixed-citation><mixed-citation xml:lang="en">O'Grady I, Anderson A, O'Sullivan J. The interplay of the oral microbiome and alcohol consumption in oral squamous cell carcinomas. Oral Oncol. 2020;110:105011. doi: 10.1016/j.oraloncology.2020.105011.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612-627. doi: 10.1016/j.oooo.2017.12.011</mixed-citation><mixed-citation xml:lang="en">Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612-627. doi: 10.1016/j.oooo.2017.12.011.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–40. doi: 10.1007/s00203-018-1505-3</mixed-citation><mixed-citation xml:lang="en">Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–40. doi: 10.1007/s00203-018-1505-3</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Healy CM, Moran GP. The microbiome and oral cancer: More questions than answers. Oral Oncol. 2019;89(1879-0593(Electronic)):30–3. doi: 10.1016/j.oraloncology.2018.12.003</mixed-citation><mixed-citation xml:lang="en">Healy CM, Moran GP. The microbiome and oral cancer: More questions than answers. Oral Oncol. 2019;89(1879-0593(Electronic)):30–3. doi: 10.1016/j.oraloncology.2018.12.003</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 2017;7(1):1834. doi: 10.1038/s41598-017-02079-3</mixed-citation><mixed-citation xml:lang="en">Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 2017;7(1):1834. doi: 10.1038/s41598-017-02079-3</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Amieva M, Peek Jr. RM. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology. 2016;150(1):64–78. doi: 10.1053/j.gastro.2015.09.004</mixed-citation><mixed-citation xml:lang="en">Amieva M, Peek Jr. RM. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology. 2016;150(1):64–78. doi: 10.1053/j.gastro.2015.09.004</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella Typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18(9):1887. doi: 10.3390/ijms18091887</mixed-citation><mixed-citation xml:lang="en">Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella Typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18(9):1887. doi: 10.3390/ijms18091887</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613–23. doi: 10.18632/oncotarget.42</mixed-citation><mixed-citation xml:lang="en">Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613–23. doi: 10.18632/oncotarget.42</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bolz J, Dosá E, Schubert J, Eckert AW. Bacterial colonization of microbial biofilms in oral squamous cell carcinoma. Clin Oral Invest. 2014;18(2):409–14. doi: 10.1007/s00784-013-1007-2</mixed-citation><mixed-citation xml:lang="en">Bolz J, Dosá E, Schubert J, Eckert AW. Bacterial colonization of microbial biofilms in oral squamous cell carcinoma. Clin Oral Invest. 2014;18(2):409–14. doi: 10.1007/s00784-013-1007-2</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf A, Moissl-Eichinger C, Perras A, Koskinen K, Tomazic PV, Thurnher D. The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study. Sci Rep. 2017;7(1):5867-5878. doi: 10.1038/s41598-017-06361-2</mixed-citation><mixed-citation xml:lang="en">Wolf A, Moissl-Eichinger C, Perras A, Koskinen K, Tomazic PV, Thurnher D. The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study. Sci Rep. 2017;7(1):5867-5878. doi: 10.1038/s41598-017-06361-2</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Amer A, Galvin S, Healy CM, Moran GP. The Microbiome of potentially malignant oral leukoplakia exhibits enrichment for fusobacterium, leptotrichia, campylobacter, and rothia species. Front Microbiol. 2017;8:2391. doi: 10.3389/fmicb.2017.02391</mixed-citation><mixed-citation xml:lang="en">Amer A, Galvin S, Healy CM, Moran GP. The Microbiome of potentially malignant oral leukoplakia exhibits enrichment for fusobacterium, leptotrichia, campylobacter, and rothia species. Front Microbiol. 2017;8:2391. doi: 10.3389/fmicb.2017.02391</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer. 2019;(1097-0215 (Electronic)). doi: 10.1002/ijc.32152</mixed-citation><mixed-citation xml:lang="en">Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer. 2019;(1097-0215 (Electronic)). doi: 10.1002/ijc.32152.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">De Ryck T, Vanlancker E, Grootaert C, Roman BI, De Coen LM, Vandenberghe I, et al. Microbial inhibition of oral epithelial wound recovery: potential role for quorum sensing molecules? AMB Express. 2015;5:27-37. doi: 10.1186/s13568-015-0116-5. eCollection 2015.</mixed-citation><mixed-citation xml:lang="en">De Ryck T, Vanlancker E, Grootaert C, Roman BI, De Coen LM, Vandenberghe I, et al. Microbial inhibition of oral epithelial wound recovery: potential role for quorum sensing molecules? AMB Express. 2015;5:27-37. doi: 10.1186/s13568-015-0116-5. eCollection 2015.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Sun F, Lin X, Li Z, Mao X, Jiang C. Cytotoxic T cell responses to Streptococcus are associated with improved prognosis of oral squamous cell carcinoma. Exp Cell Res. 2018;362(1):203–8. doi: 10.1016/j.yexcr.2017.11.018</mixed-citation><mixed-citation xml:lang="en">Wang J, Sun F, Lin X, Li Z, Mao X, Jiang C. Cytotoxic T cell responses to Streptococcus are associated with improved prognosis of oral squamous cell carcinoma. Exp Cell Res. 2018;362(1):203–8. doi: 10.1016/j.yexcr.2017.11.018</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьевская ЗВ, Терещенко ИВ, Казимов АЭ, Багирова НС, Петухова ИН, Мудунов АМ. Микробиота полости рта и ее значение в генезе рака орофарингеальной зоны. Злокачественные опухоли. 2020;(31):54-59. doi: 10.18027/2224-5057-2020-10-3s1-54-59</mixed-citation><mixed-citation xml:lang="en">Grigorievskaya ZV, Tereshchenko IV, Karimov AE, Bagirova NS, Petukhova IN, Mudunov AM. Oral microbiota and its significance in the genesis of cancer of the oropharyngeal zone. Malignant tumors. 2020;(31):54-59 (In Russ.). doi: 10.18027/2224-5057-2020-10-3s1-54-59</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2022;86(Pt 3):633-642. doi: 10.1016/j.semcancer.2021.11.002</mixed-citation><mixed-citation xml:lang="en">Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2022;86(Pt 3):633-642. doi: 10.1016/j.semcancer.2021.11.002</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yokoyama S, Takeuchi K, Shibata Y, Kageyama S, Matsumi R, Takeshita T, et al. Characterization of oral microbiota and acetaldehyde production. J Oral Microbiol. 2018;10(1):1492316. doi: 10.1080/20002297.2018.1492316</mixed-citation><mixed-citation xml:lang="en">Yokoyama S, Takeuchi K, Shibata Y, Kageyama S, Matsumi R, Takeshita T, et al. Characterization of oral microbiota and acetaldehyde production. J Oral Microbiol. 2018;10(1):1492316. doi: 10.1080/20002297.2018.1492316</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hsiao JR, Chang CC, Lee WT, Huang CC, Ou CY, Tsai ST, et al. The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma. Accepted Manuscript. 2018(1460-2180 (Electronic)). doi: 10.1093/carcin/bgy053</mixed-citation><mixed-citation xml:lang="en">Hsiao JR, Chang CC, Lee WT, Huang CC, Ou CY, Tsai ST, et al. The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma. Accepted Manuscript. 2018(1460-2180 (Electronic)). doi: 10.1093/carcin/bgy053</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Fan X, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Freedman ND, et al. Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome. 2018;6(1):59. doi: 10.1186/s40168-018-0448-x</mixed-citation><mixed-citation xml:lang="en">Fan X, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Freedman ND, et al. Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome. 2018;6(1):59. doi: 10.1186/s40168-018-0448-x.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ho J, Camilli G, Griffiths JS, Richardson JP, Kichik N, Naglik JR. Candida albicans and candidalysin in inflammatory disorders and cancer. Immunology. 2021;162(1):11-16. doi: 10.1111/imm.13255</mixed-citation><mixed-citation xml:lang="en">Ho J, Camilli G, Griffiths JS, Richardson JP, Kichik N, Naglik JR. Candida albicans and candidalysin in inflammatory disorders and cancer. Immunology. 2021;162(1):11-16. doi: 10.1111/imm.13255</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders. J Oral Pathol Med. 2013;42(3):243–9. doi: 10.1111/j.1600-0714.2012.01203.x</mixed-citation><mixed-citation xml:lang="en">Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders. J Oral Pathol Med. 2013;42(3):243–9. doi: 10.1111/j.1600-0714.2012.01203.x</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Багирова НС, Петухова ИН, Григорьевская ЗВ, Сытов АВ, Слукин ПВ, Горемыкина ЕА, и др. Микробиота полости рта у больных раком орофарингеальной области с акцентом на candida spp. Candida spp. Опухоли головы и шеи. 2022;12(3):71-85 doi: 10.17650/2222-1468-2022-12-3-71-85</mixed-citation><mixed-citation xml:lang="en">Bagirova NS, Petukhova IN, Grigorievskaya ZV, Sytov AV, Slukin PV, Goremykina EA, et al. Oral microbiota in patients with oropharyngeal cancer with an emphasis on Candida spp. Head and Neck Tumors (HNT). 2022;12(3):71-85 (In Russ.). doi: 10.17650/2222-1468-2022-12-3-71-85</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: A matched casecontrol study. Oral Oncol. 2015;51(2):139–45. doi: 10.1016/j.oraloncology.2014.11.008</mixed-citation><mixed-citation xml:lang="en">Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: A matched casecontrol study. Oral Oncol. 2015;51(2):139–45. doi: 10.1016/j.oraloncology.2014.11.008</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin North Am. 2018;62(1):111-120. doi: 10.1016/j.cden.2017.08.008</mixed-citation><mixed-citation xml:lang="en">Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin North Am. 2018;62(1):111-120. doi: 10.1016/j.cden.2017.08.008</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Reich M, Licitra L, Vermorken JB, Bernier J, Parmar S, Golusinski W, et al. Best practice guidelines in the psychosocial management of hpv-related head and neck cancer: Recommendations from the european head and neck cancer society’s make sense campaign. Ann Oncol. 2016;27(10):1848–54. doi: 10.1093/annonc/mdw272</mixed-citation><mixed-citation xml:lang="en">Reich M, Licitra L, Vermorken JB, Bernier J, Parmar S, Golusinski W, et al. Best practice guidelines in the psychosocial management of hpv-related head and neck cancer: Recommendations from the european head and neck cancer society’s make sense campaign. Ann Oncol. 2016;27(10):1848–54. doi: 10.1093/annonc/mdw272</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Purkayastha M, McMahon AD, Gibson J, Conway DI. Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975–2012) – A socioeconomic perspective. Oral Oncol. 2016;61:70–75. doi: 10.1016/j.oraloncology.2016.08.015</mixed-citation><mixed-citation xml:lang="en">Purkayastha M, McMahon AD, Gibson J, Conway DI. Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975–2012) – A socioeconomic perspective. Oral Oncol. 2016;61:70–75. doi: 10.1016/j.oraloncology.2016.08.015</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–3242. doi: 10.1200/JCO.2015.61.6995</mixed-citation><mixed-citation xml:lang="en">Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–3242. doi: 10.1200/JCO.2015.61.6995</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, et al. Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiol. 2021;75:102020. doi: 10.1016/j.canep.2021.102020</mixed-citation><mixed-citation xml:lang="en">Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, et al. Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiol. 2021;75:102020. doi: 10.1016/j.canep.2021.102020</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patientyoung, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-380. doi: 10.1177/0194599814538605</mixed-citation><mixed-citation xml:lang="en">Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patientyoung, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-380. doi: 10.1177/0194599814538605</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Javadi P, Sharma A, Zahnd WE, Jenkins WD. Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers. Cancer; Causes Control. 2017;28(1573–7225. doi: 10.1007/s10552-017-0889-8</mixed-citation><mixed-citation xml:lang="en">Javadi P, Sharma A, Zahnd WE, Jenkins WD. Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers. Cancer; Causes Control. 2017;28(1573–7225. doi: 10.1007/s10552-017-0889-8</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Mehrpour M, Codogno P. Prion protein: From physiology to cancer biology. Cancer Lett. 20101;290(1):1-23. doi: 10.1016/j.canlet.2009.07.009</mixed-citation><mixed-citation xml:lang="en">Mehrpour M, Codogno P. Prion protein: From physiology to cancer biology. Cancer Lett. 20101;290(1):1-23. doi: 10.1016/j.canlet.2009.07.009</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lebreton S, Zurzolo C, Paladino S. Organization of GPI-anchored proteins at the cell surface and its physiopathological relevance. Crit Rev Biochem Mol Biol. 2018;53(4):403-419. doi: 10.1080/10409238.2018.1485627</mixed-citation><mixed-citation xml:lang="en">Lebreton S, Zurzolo C, Paladino S. Organization of GPI-anchored proteins at the cell surface and its physiopathological relevance. Crit Rev Biochem Mol Biol. 2018;53(4):403-419. doi: 10.1080/10409238.2018.1485627</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Santos TG, Lopes MH, Martins VR. Targeting prion protein interactions in cancer. Prion. 2015;9(3):165-73. doi: 10.1080/19336896.2015.1027855 45. Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules. 2022;27(3):705. doi: 10.3390/molecules27030705</mixed-citation><mixed-citation xml:lang="en">Santos TG, Lopes MH, Martins VR. Targeting prion protein interactions in cancer. Prion. 2015;9(3):165-73. doi: 10.1080/19336896.2015.1027855 45. Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules. 2022;27(3):705. doi: 10.3390/molecules27030705</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Yang X, Cheng Z, Zhang L, Wu G, Shi R, Gao Z, et al. Prion Protein Family Contributes to Tumorigenesis via Multiple Pathways. Adv Exp Med Biol. 2017;1018:207-224. doi: 10.1007/978-981-10-5765-6_13</mixed-citation><mixed-citation xml:lang="en">Yang X, Cheng Z, Zhang L, Wu G, Shi R, Gao Z, et al. Prion Protein Family Contributes to Tumorigenesis via Multiple Pathways. Adv Exp Med Biol. 2017;1018:207-224. doi: 10.1007/978-981-10-5765-6_13</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, et al. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer. Int J Cancer. 2014;135(10):2329-37. doi: 10.1002/ijc.28883</mixed-citation><mixed-citation xml:lang="en">Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, et al. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer. Int J Cancer. 2014;135(10):2329-37. doi: 10.1002/ijc.28883</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Yun CW, Lee JH, Go G, Jeon J, Yoon S, Lee SH. Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer. Cancers (Basel). 2021;13(9):2144. doi: 10.3390/cancers13092144</mixed-citation><mixed-citation xml:lang="en">Yun CW, Lee JH, Go G, Jeon J, Yoon S, Lee SH. Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer. Cancers (Basel). 2021;13(9):2144. doi: 10.3390/cancers13092144</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mouillet-Richard S, Martin-Lannerée S, Le Corre D, Hirsch TZ, Ghazi A, Sroussi M, et al. A proof of concept for targeting the PrPC – Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer. Oncogene. 2022;41(38):4397-4404. doi: 10.1038/s41388-022-02430-7</mixed-citation><mixed-citation xml:lang="en">Mouillet-Richard S, Martin-Lannerée S, Le Corre D, Hirsch TZ, Ghazi A, Sroussi M, et al. A proof of concept for targeting the PrPC – Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer. Oncogene. 2022;41(38):4397-4404. doi: 10.1038/s41388-022-02430-7</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Gil M, Kim YK, Kim KE, Kim W, Park CS, Lee KJ. Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity. Biochem Biophys Res Commun. 2016;470(1):213-219. doi: 10.1016/j.bbrc.2016.01.038</mixed-citation><mixed-citation xml:lang="en">Gil M, Kim YK, Kim KE, Kim W, Park CS, Lee KJ. Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity. Biochem Biophys Res Commun. 2016;470(1):213-219. doi: 10.1016/j.bbrc.2016.01.038</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Corsaro A, Bajetto A, Thellung S, Begani G, Villa V, Nizzari M, et al. Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget. 2016;7(25):38638-38657. doi: 10.18632/oncotarget.9575</mixed-citation><mixed-citation xml:lang="en">Corsaro A, Bajetto A, Thellung S, Begani G, Villa V, Nizzari M, et al. Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget. 2016;7(25):38638-38657. doi: 10.18632/oncotarget.9575</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Казимов АЭ, Григорьевская ЗВ, Кропотов МА, Багирова НС, Петухова ИН, Терещенко ИВ, и др. Пародонтопатогенная микрофлора как фактор риска развития плоскоклеточного рака слизистой оболочки полости рта. Опухоли головы и шеи. 2021;11(3):83-93. doi: 10.17650/2222-1468-2021-11-3-83-93</mixed-citation><mixed-citation xml:lang="en">Kazimov AE, Grigorievskaya ZV, Kropotov MA, Bagirova NS, Petukhova IN, Tereshchenko IV, et al. Periodontal pathogens as a risk factor for oral squamous cell carcinoma. Head and Neck Tumors (HNT). 2021;11(3):83-93 (In Russ.). doi: 10.17650/2222-1468-2021-11-3-83-93</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Komlós G, Csurgay K , Horváth F, Pelyhe L, Németh Z. Periodontitis as a risk for oral cancer: a casecontrol study. BMC Oral Health. 2021;21(1):640. doi: 10.1186/s12903-021-01998-y</mixed-citation><mixed-citation xml:lang="en">Komlós G, Csurgay K , Horváth F, Pelyhe L, Németh Z. Periodontitis as a risk for oral cancer: a casecontrol study. BMC Oral Health. 2021;21(1):640. doi: 10.1186/s12903-021-01998-y</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Capella DL, Gonçalves JM, Abrantes AAA, Grando LJ, Daniel FI. Proliferative verrucous leukoplakia: diagnosis, management and current advances. Braz J Otorhinolaryngol. 2017;83(5):585-593. doi: 10.1016/j.bjorl.2016.12.005</mixed-citation><mixed-citation xml:lang="en">Capella DL, Gonçalves JM, Abrantes AAA, Grando LJ, Daniel FI. Proliferative verrucous leukoplakia: diagnosis, management and current advances. Braz J Otorhinolaryngol. 2017;83(5):585-593. doi: 10.1016/j.bjorl.2016.12.005</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Parashar P. Proliferative verrucous leukoplakia: an elusive disorder. J Evid Based Dent Pract. 2014;14 Suppl:147-53.e1. doi: 10.1016/j.jebdp.2014.04.005</mixed-citation><mixed-citation xml:lang="en">Parashar P. Proliferative verrucous leukoplakia: an elusive disorder. J Evid Based Dent Pract. 2014;14 Suppl:147-53.e1. doi: 10.1016/j.jebdp.2014.04.005</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Munde A, Karle R. Proliferative verrucous leukoplakia: an update. J Cancer Res Ther. 2016;12:469-4673. doi: 10.4103/0973-1482.151443</mixed-citation><mixed-citation xml:lang="en">Munde A, Karle R. Proliferative verrucous leukoplakia: an update. J Cancer Res Ther. 2016;12:469-4673. doi: 10.4103/0973-1482.151443</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Bagan JV, Jiménez-Soriano Y, Diaz-Fernandez JM, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Oral Oncol. 2011;47:732-735. doi: 10.1016/j.oraloncology.2011.05.008</mixed-citation><mixed-citation xml:lang="en">Bagan JV, Jiménez-Soriano Y, Diaz-Fernandez JM, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Oral Oncol. 2011;47:732-735. doi: 10.1016/j.oraloncology.2011.05.008</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Akrish S, Ben-Izhak O, Sabo E, Rachmiel A. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma – a clinical, histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:318-325. doi: 10.1016/j.oooo.2014.10.023</mixed-citation><mixed-citation xml:lang="en">Akrish S, Ben-Izhak O, Sabo E, Rachmiel A. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma – a clinical, histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:318-325. doi: 10.1016/j.oooo.2014.10.023</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Пархоменко ЛБ. Рак органов головы и шеи и предрасполагающие к нему факторы. Медицинские новости. 2018;(9):3-9. Режим доступа: https://cyberleninka.ru/article/n/rak-organov-go-lovy-i-shei-i-predraspolagayuschie-k-nemu-faktory</mixed-citation><mixed-citation xml:lang="en">Parkhomenko LB. Head and neck Cancer and peventing factors. Medical news. 2018;9(288):3-9 (In Russ.). Available from: https://cyberleninka.ru/article/n/rak-organov-go-lovy-i-shei-i-predraspolagayuschie-k-nemu-faktory</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesion. J Am Dent Assoc. 2014;145:45-56. doi: 10.14219/jada.2013.10</mixed-citation><mixed-citation xml:lang="en">Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesion. J Am Dent Assoc. 2014;145:45-56. doi: 10.14219/jada.2013.10</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Aghbari SMH, Abushouk AI, Attia A, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102. doi: 10.1016/j.oraloncology.2017.03.012</mixed-citation><mixed-citation xml:lang="en">Aghbari SMH, Abushouk AI, Attia A, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102. doi: 10.1016/j.oraloncology.2017.03.012</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Casparis S, Borm JM, Tektas S, Kamarachev J, Locher MC, Damerau G, Grätz KW, Stadlinger B. Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011. Oral Maxillofac Surg. 2015;19:149-156. doi: 10.1007/s10006-014-0469-y</mixed-citation><mixed-citation xml:lang="en">Casparis S, Borm JM, Tektas S, Kamarachev J, Locher MC, Damerau G, Grätz KW, Stadlinger B. Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011. Oral Maxillofac Surg. 2015;19:149-156. doi: 10.1007/s10006-014-0469-y</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Sperandio M, Klinikowski MF, Brown AL, Hirlaw PJ, Challacombe SJ, Morgan PR, Warnakulasuriya S, Odell EW. Image-based DNA ploidy analysis aids prediction of malignant transformation in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:643-650. doi: 10.1016/j.oooo.2016.02.008</mixed-citation><mixed-citation xml:lang="en">Sperandio M, Klinikowski MF, Brown AL, Hirlaw PJ, Challacombe SJ, Morgan PR, Warnakulasuriya S, Odell EW. Image-based DNA ploidy analysis aids prediction of malignant transformation in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:643-650. doi: 10.1016/j.oooo.2016.02.008</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020;112(10):1047-1054. doi: 10.1093/jnci/djz238</mixed-citation><mixed-citation xml:lang="en">Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020;112(10):1047-1054. doi: 10.1093/jnci/djz238</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Сандакова ДЦ, Васильева ТВ. Предраки полости рта: лейкоплакия. Теория и практика современной стоматологии. 2022:249-253. Режим доступа: https://elibrary.ru/item.asp?id=48435907</mixed-citation><mixed-citation xml:lang="en">Sandakova DTs, Vasilyeva TV. Precancerous oral cavity: leukoplakia. Theory and practice of modern dentistry. 2022:249-253 (In Russ.). Available from: https://elibrary.ru/item.asp?id=48435907</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Старикова ИВ, Дибцева ТС, Гордеева ОВ, Иваненко АИ. Распространненность лейкоплакии в структуре заболеваний слизистой оболочки полости рта. In Colloquium-journal. 2018;(7-2):23-24. Режим доступа: https://www.elibrary.ru/item.asp?id=35306833</mixed-citation><mixed-citation xml:lang="en">Starikova IV, Dibtseva TS, Gordeeva OV, Ivanenko AI. Prevalence of the leukoplakia in structure of diseases of the mucous membrane of the oral cavity. In Colloquiumjournal. 2018;7-2:23-24 (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=35306833</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Nocini R, Lippi G, Mattiuzzi C. Biological and epidemiologic updates on lip and oral cavity cancers. Ann Cancer Epidemiol. 2020;4:1. doi: 10.21037/ace.2020.01.01</mixed-citation><mixed-citation xml:lang="en">Nocini R, Lippi G, Mattiuzzi C. Biological and epidemiologic updates on lip and oral cavity cancers. Ann Cancer Epidemiol. 2020;4:1. doi: 10.21037/ace.2020.01.01</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Гимаева РР, Куприянова ЕА, Габелко ДИ. Мутации в генах BRCA1 и BRCA2 как этиологический фактор наследственного рака молочной железы. Вестник современной клинической медицины. 2020;13(4):39-43. doi: 10.20969/VSKM.2020.13(4).39-43</mixed-citation><mixed-citation xml:lang="en">Gimaeva RR, Kupriyanova EA, Gabelko DI. Mutations in BRCA1 and BRCA2 genes as a cause of hereditary breast cancer. Bulletin of ContemporaryClinical Medicine. 2020;13(4):39-43 (In Russ.). doi: 10.20969/VSKM.2020.13(4).39-43</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Василькевич МИ, Савоневич ЕЛ., Хомбак АМ. Рак молочной железы: Особенности анамнеза и спектра герминальных мутаций генов BRCA. Endless light in science. 2023;(2):35-39. Режим доступа: https://cyberleninka.ru/article/n/rak-molochnoyzhelezy-osobennosti-anamneza-i-spektra-germinalnyh-mutatsiy-genov-brca</mixed-citation><mixed-citation xml:lang="en">Vasilkevich MI, Savonevich EL, Hombak AM. Breast cancer: Features of anamnesis and spectrum of germinal mutations of BRCA genes. Endless light in science. 2023;(2):35-39 (In Russ.). Available from: https://cyberleninka.ru/article/n/rak-molochnoyzhelezy-osobennosti-anamneza-i-spektra-germinalnyh-mutatsiy-genov-brca</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Куликов ЕП, Григоренко ВА, Мерцалов СА, Судаков АИ. Полиморфизмы генов TNF и MMP1 и их ассоциация с клиническими аспектами колоректального рака. Экспериментальная и клиническая гастроэнтерология. 2022;(10):103-110. doi: 10.31146/1682-8658-ecg-206-10-103-110</mixed-citation><mixed-citation xml:lang="en">Kulikov EP, Grigorenko VA, Mertsalov SA, Sudakov AI. TNF and MMP1 gene polymorphisms and their association with clinical aspects of colorectal cancer. Experimental and Clinical Gastroenterology. 2022;(10):103-110 (In Russ.). doi: 10.31146/1682-8658-ecg-206-10-103-110</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Журман ВН, Плехова НГ, Филипенко МЛ. Мутационный статус генов BRCA при раке яичников. Обзор І Review Eurasian Journal of Oncology. 2022;10(2):118-125. doi: 10.34883/PI.2022.10.2.016</mixed-citation><mixed-citation xml:lang="en">Zhurman VN, Plekhova NG, Filipenko ML. Mutational status of BRCA genes in ovarian cancer. Eurasian Journal of Oncology. 2022;10(2):118-125 (In Russ.). doi: 10.34883/PI.2022.10.2.016</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Киселева АЭ, Зезюлина АФ, Микерова МС, Быков ИИ, Решетов ИВ. Клиническое значение мутации гена CDH1 при раке желудка. Онкология. Журнал им. П.А. Герцена. 2022;11(2):74-79. doi: 10.17116/onkolog20221102174</mixed-citation><mixed-citation xml:lang="en">Kiseleva AE, Zezyulina AF, Mikerova MS, Bykov II, Reshetov IV. Clinical value of CDH1 gene in gastric cancer. P.A. Herzen Journal of Oncology. 2022;11(2):74-79 (In Russ.). doi: 10.17116/onkolog20221102174</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Venugopal R, Bavle RM, Konda P, Muniswamappa S, Makarla S. Familial Cancers of Head and Neck Region. J Clin Diagn Res. 2017;11(6):ZE01-ZE06. doi: 10.7860/JCDR/2017/25920.9967</mixed-citation><mixed-citation xml:lang="en">Venugopal R, Bavle RM, Konda P, Muniswamappa S, Makarla S. Familial Cancers of Head and Neck Region. J Clin Diagn Res. 2017;11(6):ZE01-ZE06. doi: 10.7860/JCDR/2017/25920.9967</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
